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Abstract
Accumulation of DNA damage caused by oxidative stress is thought to be one of the main contributors of human tissue
aging. Trichothiodystrophy (TTD) mice have a mutation in the Ercc2 DNA repair gene, resulting in accumulation of DNA
damage and several features of segmental accelerated aging. We used male TTD mice to study the impact of DNA repair on
bone metabolism with age. Analysis of bone parameters, measured by micro-computed tomography, displayed an earlier
decrease in trabecular and cortical bone as well as a loss of periosteal apposition and a reduction in bone strength in TTD
mice with age compared to wild type mice. Ex vivo analysis of bone marrow differentiation potential showed an accelerated
reduction in the number of osteogenic and osteoprogenitor cells with unaltered differentiation capacity. Adipocyte
differentiation was normal. Early in life, osteoclast number tended to be increased while at 78 weeks it was significantly
lower in TTD mice. Our findings reveal the importance of genome stability and proper DNA repair for skeletal homeostasis
with age and support the idea that accumulation of damage interferes with normal skeletal maintenance, causing reduction
in the number of osteoblast precursors that are required for normal bone remodeling leading to a loss of bone structure
and strength.
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Introduction
Osteoporosis, caused by a natural loss of estrogens, has been the
main focus of the bone field for many years. However, recently a
growing body of evidence supports a more general, age-related
form of bone loss, which occurs independent of changes in sex
steroid hormone levels and starts at an early age [1]. Epidemi-
ological studies pin-point the onset of this age-related bone loss
right after obtaining peek bone mass in humans [2,3]. Addition-
ally, early onset and gradual bone loss has also been found in
several mouse strains independent of a sudden loss of estrogens
starting 2–3 months after birth [4,5]. This age-related bone loss is
characterised by a slower, more gradual decline in bone mass than
in case of post menopausal bone loss [6].
Oxidative stress has been postulated as one of the contributing
mechanisms behind age-related bone loss [1]. Oxidative stress is
induced by reactive oxygen species (ROS) formed as by-products
of mitochondrial aerobic metabolism and fatty acid oxidation [7].
ROS at basal levels play an important role in a broad spectrum of
signalling pathways [8]. An increase in ROS production in
response to external stimuli can induce oxidative stress which
causes DNA and protein damage that can lead to apoptosis [9]. All
cells have a battery of defence mechanisms to prevent ROS-
induced damage. Anti-oxidant enzymes scavenge ROS and
reduce them to an inactive state. Additionally, ROS activate
proteins, including forkhead box protein O (FOXO) transcription
factors that regulate anti-oxidant enzyme expression and activate
DNA repair pathways [10,11]. Besides ROS, cellular metabolism
also produces various other reactive chemical species, with a
tendency to damage DNA such as alkylating agents and reactive
nitrogen species. Recent studies showed the importance of
FOXO-mediated oxidative stress defence for osteoblast function
and skeletal homeostasis [12,13].
Cells contain several DNA repair pathways. The global genome
nucleotide excision repair (GG-NER) pathway removes helix-
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distorting damage anywhere in the genome, thus mainly
preventing mutagenesis and consequently carcinogenesis. Tran-
scription coupled repair (TCR) eliminates lesions in the tran-
scribed strand of active genes when transcription is arrested by
DNA damage, to allow rapid resumption of the vital transcription
process. This repair system mainly promotes cell survival and
prevents DNA damage induced cell death and senescence [14,15].
Both repair processes share a number of components, including
the 10-subunit transcription factor II H (TFIIH) complex [16].
TFIIH opens up the DNA helix using the helicases xeroderma
pigmentosum complementation group B (XPB) and D (XPD) after
damage detection in global genome as well as transcription-
coupled repair [17]. This allows damage verification and excision
by dual incision of the damaged strand at some distance from the
lesion, followed by gap-filling DNA synthesis and final ligation to
the pre-existing strand [18].
Mutations in the NER pathway helicase XPD, cause -among
several other inherited syndromes- a disease called Trichothiody-
strophy (TTD) which is a rare, autosomal recessive DNA repair
disorder presenting a wide range of characteristic features like
photosensitivity, brittle hair and nails, impaired intelligence, short
stature, infertility and a severely reduced lifespan. Additionally,
skeletal abnormalities have been described [19]. An XPD mouse
model was generated, using murine homologue Ercc2, which
precisely mimics a causative point mutation in the essential Xpd
gene of a TTD patient, causing a single amino acid substitution
(R722W) in the ERCC2 (XPD) helicase. Although mice were
significantly lighter and smaller, radiographs of 2- to 4- month old
TTD mice did not show any skeletal abnormalities, but those of 14
month old mice displayed kyphosis and a reduction in radiodensity
of the long bones, both hallmarks of human aging [20]. In
addition, TTD mice in a C57BL/6J background, have strikingly
similar symptoms and show several premature aging-like features
[21].
We used the TTD mouse model, which lacks one of the basic
defense mechanisms against DNA damage and undergoes
accelerated aging, to study the impact of DNA-repair in
maintaining bone metabolism with aging. Previous studies using
TTD mice have shown that early TTD development progresses
normally when compared to wild type mice. Clear changes
between the two groups start to develop after 26 weeks of age
when TTD mice start to lag behind in gaining body weight and
develop their characteristic features [22]. Early bone development
was not affected and no changes in bone length were measured in
male or female bones at any of the time points studied (data not
shown). In this study we investigated bone architecture, gene
expression and mesenchymal and hematopoietic stem cell
differentiation potential.
Results
Bone Architecture
In order to analyze bone dynamics in wild type and TTD mice
throughout life we analyzed trabecular bone parameters in the
metaphysis by mCT analysis. The trabecular bone volume fraction
(BV/TV) gradually but significantly decreased over time in wild
type mice, dropping 75% between 13 and 104 weeks of age. Albeit
that at 13 weeks the BV/TV in TTD mice was already half of that
in wild type mice, BV/TV decreased as well further throughout
life, losing about 50% between 26 and 78 weeks of age (Fig. 1A).
At all time points measured, BV/TV was significantly lower
between wild type and TTD mice, with the largest difference
observed at the first point measured at 26 weeks of age. No
significant interaction between genotype and age was observed.
The endocortical volume (Ec.V.), also known as the total volume
contained by the endosteal surface of the cortical bone, was
significantly lower in 13 weeks old TTD mice compared to wild
type mice of the same age. Ec.V. decreased between 13 and 26
weeks in both wild type and TTD mice after which it stabilized in
wild type mice. Ec.V. increased again In TTD mice, ending up
significantly higher at 52 and 78 weeks of age compared to wild
type mice (Fig. 1B). For Ec.V. there was a significant interaction
between genotype and age, which means that age is a determinant
of the difference between wild type and TTD mice. Trabecular
number (Tb.N.) which decreased in wild types throughout life, is
significantly lower in TTD mice, with the biggest difference
observed at 13 weeks when TTD mice have about half the number
of trabecules found in wild type mice of the same age (Fig. 1C).
Trabecular thickness (Tb.Th.) however, was the same for both
genotypes and did not change throughout life (Fig. 1D). In
summary, TTD mice (Fig. 1F) displayed a reduction in trabecular
bone compared to age-matched wild type mice (Fig. 1E) as shown
in the sample cross-sections in Figure 1E and F. In addition, both
wild type and TTD exhibited age-related decline.
Cortical thickness (Ct.Th.) significantly decreased throughout
life in wild type mice, losing approximately 20% between 13 and
104 weeks. The same gradual and significant decline was observed
in TTD mice, which had thinner cortices compared to wild type
mice at all time points measured, significantly so at 26 and 78
weeks (Fig. 2A). Cortical volume (Ct.V.) increased between 13 and
26 weeks after which it remained initially relatively stable in wild
type mice, but rapidly and significantly dropped between 78 and
104 weeks of age reaching a level that is already obtained in TTD
mice at 52 weeks. In TTD mice, Ct.V. also increased in the first
time period, but less than in wild type mice, after which it
stabilized throughout life but was significantly lower at all time
points compared to wild type mice of the same age (Fig. 2B).
Statistical analysis showed a significant interaction between age
and genotype, which translated into a significant decrease in Ct.V.
over time in TTD mice compared to wild type mice. Endocorital
volume (Ec.V) followed a similar pattern in time as Ct.V (Fig. 2C).
After the initial increase TTD mice have a relatively stable but
significantly increased endocortical volume compared to wild type
mice throughout their entire life. Ec.V. is stable up to 78 weeks of
age in wild type mice after which it rapidly and significantly
increases, reaching TTD levels (Fig. 2C). Analysis of the 3D
thickness distribution within the diaphysis demonstrated a shift
towards thinner bone fragments as well as a drop in the number of
fragments when comparing young and old wild type as well as
TTD mice. This is depicted for wild type mice in Figure 2D.
Importantly, an accelerated age-related shift towards thinner
fragments was observed in TTD mice when compared to wild type
mice (Fig. 2D). In general, at the age of 6 months, TTD mice
(Fig. 2F) already have much thinner cortices and less cortical bone
compared to age-matched wild type mice (Fig. 2E).
Data of histomorphometric analyses on 13 and 78 week old wild
type and TTD tibiae are shown in Table 1. None of the eleven
studied histomorphometric parameters were significantly different
at 13 weeks (Table 1). In contrast in 78 week old mice, several
parameters were significantly lower in TTD mice, including Tb.N,
Tb.Th. and BV/TV, supporting the mCT findings, while
trabecular spacing (Tb.Sp) was significantly higher in TTD mice.
For most parameters a significant interaction between age and the
TTD genotype was shown (Table 1).
Bone Strength
Structural changes in bone architecture, like differences in
cortices and alterations in matrix deposition can lead to changes in
Loss of Bone Strength in Male TTD Mice
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35246
bone strength. To address this, we performed 3-point bending tests
on wild type and TTD femurs. We measured three parameters;
energy to failure, ultimate load and stiffness[23]. The amount of
energy needed to break the bone – energy to failure – is with aging
significantly lower in TTD that in wild type, but there was no
significant interaction between genotype and age (Fig. 3A).
Wild type bones showed a gradual decrease in ulitmate force,
reflecting general integrity of the bone structure, dropping from
18 N to 15.5 N over a period of 65 weeks (Fig. 3B). Ultimate force
was similar in wild type and TTD mices at 13 weeks of age,
consistent with the idea that initial bone development in TTD is
not significantly affected. At 26 weeks, however, a drop to about
12.5 N was observed, which is in line with the differences found
with other parameters at this age between TTD and wild type
males. Bone stiffness was significantly decreased from 13 weeks
onwards, with the exception of 26 week old bones (Fig. 3C).
Quantitative backscatter scanning electron microscopic analysis of
wild type and TTD femurs displayed no significant differences in
Figure 1. Age-related trabecular bone loss in male TTD mice. Trabecular bone parameters (A-D) were studied in aging wild type (solid) and
TTD (open) tibial metaphyses. (A) Trabecular bone volume fraction (BV/TV), (B) Endocortical volume (Ec.V.), (C) Trabecular number (Tb.N.), (D)
Trabecular thickness (Tb.Th.). 100 cross-sections were measured in the metaphysis of TTD and wild type mice. Representative cross-sections of 26
week old, male, wild type (E) and TTD mice (F) depict the loss of trabecular bone, the decrease in trabecular number and increase in endocortical
volume. Statistics: a = student t-test; p,0.05 wild type vs. TTD, b2d = 2 way ANOVA; p,0.05. b = significant difference between wild type and TTD
with aging, c = signifcant difference with aging within a genotype, d = a significant interaction between age and genotype. Error bars represent SEM.
doi:10.1371/journal.pone.0035246.g001
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mineralization of the cortex between genotypes or with aging
(Fig. 3D). Two mCT parameters related to bone strength, moment
of inertia (MOI) and perimeter (Pm.), did not show significant
differences between wild type and TTD mice throughout life and
followed similar patterns (Fig. 3E and Fig. 3F). MOI decreases
gradually during life in both wild type and TTD mice as expected,
since older bones usually become more fragile. Although the
difference is not significant, TTD mice have consistently lower
MOI values compared to wild type mice up to 78 weeks. In wild
type mice in which an additional time point of 2 years was
available, we observed a significant increase in perimeter after 78
weeks.
Figure 2. Age-related cortical bone loss in male TTD mice. Cortical bone parameters (A-D) were studied in aging wild type (solid) and TTD
(open) tibial diaphyses.(A) Cortical thickness (Ct.Th.), (B) cortical volume (Ct.V.), (C) endocortical volume (Ec.V.), (D) 3D thickness distribution. Figures E
and F depict the significant decrease in cortical thickness when comparing 26 week old wild type (E) and TTD (F) mice. Statistics: a = student t-test;
p,0.05 wild type vs. TTD, b2d = 2 way ANOVA; p,0.05. b = significant difference between wild type and TTD with aging, c = signifcant difference
with aging within a genotype, d = a significant interaction between age and genotype. Error bars represent SEM.
doi:10.1371/journal.pone.0035246.g002
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Periosteal Apposition
An increase in bone perimeter at an older age is a distinctive
feature of periosteal apposition, which generally takes place in
aging bones in order to maintain bone strength by depositing new
bone on the outside (periosteal) of the cortex in order to
compensate for the intrinsic bone loss on the inside (endosteal).
To address this further we measured periosteal bone formation
rates using calcein labeling in wild type and TTD mice (Fig. 4A
and Fig. 4B). Periosteal apposition was significantly reduced in old
but not in young TTD mice (Fig. 4C). Endosteal bone formation
was stable and unaffected throughout life (Fig. 4D).
Serum osteocalcin measurements demonstrated that at 52 weeks
but not yet at 13 weeks of age TTD mice a have significant lower
level of this bone formation parameter (Figure 4E). A character-
istic phenotype of TTD mice is that they lack development of
adipose tissue with aging [20]. This is reflected by the significant
difference we measured in the adipocyte-derived cytokine leptin
(Figure 4F). Irrespective of this strong difference the TTD were
able to control their serum glucose level and maintain similar
levels as the wild type mice (Figure 4G).
Gene Expression
In order to gain more insight into the effects of a mutated Ercc2
(Xpd) gene on transcription in general and bone formation and
remodeling specifically, we isolated RNA from tibiae and
measured the expression levels of a number of osteoblast and
osteoclast specific genes. Osteocalcin (Bglap) and collagen (Col1A1)
were expressed at similar levels in wild type and TTD tibiae, both
at 13 and 52 weeks. However, from 13 to 52 weeks of age,
expression levels significantly decreased (Figs. 5A and B). Two well
known osteoclast markers tartrate-resistant acid phosphatase
(TRAP/ACP5) and cathepsin K (CTSK) were expressed at equal
levels in wild type and TTD tibiae at both ages analyzed (Figs 5C
and D). Similar as for the osteoblast markers, both Trap and Ctsk
expression significantly decreased from 13 to 52 weeks of age.
Recently, the importance of the FOXO-mediated oxidative
stress defence for osteoblast function and skeletal homeostasis has
started to become clear [12,13]. We studied the expression
patterns of three Foxo genes as well as those of the three
superoxide scavengers, Sod1, Sod2 and Sod3. Foxo1 was signifi-
cantly lower at 13 weeks in TTD mice, whereas Foxo3 and Foxo4
were expressed at similar levels as in wild type tibiae. In 52 week
old tibiae however, Foxo3 and Foxo4 expression was significantly
decreased in TTD mice whereas Foxo1 expression was similar in
both genotypes (Fig. 5C). Both Foxo1 and Foxo4, but not Foxo3,
levels dropped when comparing 13 weeks old mice to 52 weeks
old mice (Figs. 5C-E). All 3 Sod genes were expressed at similar
levels in wild type and TTD mice throughout life. Sod3 expression
decreased from 13 to 52 weeks of age, whereas Sod1 and Sod2
expression remained at the same level in older mice (Fig. 5D).
Next we analyzed the expression of pro- and anti-apoptotic genes
in wild type and TTD mice at various ages. No significant
difference in expression was observed at 13 and 52 weeks
indicating that the observed skeletal phenotype in TTD mice is
independent of apoptosis. At 104 weeks of age no consistent
expression was observed supporting increased or decreased
apoptosis. Pro-apoptotic genes were either higher (Casp7 and
Casp9) or lower (Casp3 and Casp6) expressed in TTD tibiae
(Figure S1).
Bone Marrow Differentiation Potential
Besides a decrease in bone strength and a lack of periosteal
apposition, older TTD mice also have a lack of body fat
[21,22,24]. This could possibly be due to impairment in the
number and/or differentiation capacity of mesenchymal stem cell
(MSC), the common precursor of osteoblasts and adipocytes. In
order to study this we isolated bone marrow containing MSCs and
osteogenic and adipogenic progenitors from 26, 42 and 78 week
old wild type and TTD mice and analyzed differentiation into
osteoblasts and adipocytes in ex vivo cultures. In addition, we
examined the osteoclastogenesis in these bone marrow samples.
The number of alkaline phosphatase (ALP) positive colonies
formed in TTD mice showed a significant age-dependent decrease
and was at 42 and 78 weeks significantly lower than in wild type
mice (Fig. 6A). No significant changes in colony size were
measured with aging in wild type and TTD cells, and no
significant differences between wild type and TTD cultures were
observed indicating that at least in vitro proliferative potential was
unaffected by aging and the TTD repair defect (Fig. 6B). Both wild
type and TTD colonies mineralized to the same extent implicating
Table 1. Histomorphometric analyses.
WT 13w
(average ± SD)
TTD 13w
(average ± SD) p-value
WT 78w
(average ± SD)
TTD 78w
(average ± SD) p-value
Interaction
(p - value)
BV/TV (%) 4.06 6 0.45 5.66 6 0.84 0.19 7.47 6 2.34 0.33 6 0.10 0.05 * 0.003*
OV/BV (%) 1.02 6 0.34 1.43 6 0.68 0.65 0.43 6 0.26 0.00 6 0.00 0.07 0.311
OS/BS (%) 10.11 6 1.62 20.35 6 6.27 0.21 6.54 6 3.51 0.00 6 0.00 0.10 0.034*
ObS/BS (%) 10.48 6 1.53 19.69 6 5.56 0.20 6.19 6 3.20 0.17 6 0.15 0.05 * 0.022*
OcS/BS (%) 1.97 6 0.26 2.74 6 0.80 0.44 1.19 6 0.23 0.00 6 0.00 0.27 0.102
Tb.Th. (mm) 17.68 6 1.14 22.11 6 1.33 0.06 25.20 6 3.71 10.94 6 2.61 0.05 * 0.002*
O.Th. (mm) 0.77 6 0.06 0.79 6 0.19 0.93 0.62 6 0.19 0.00 6 0.00 0.07 0.032*
NOb/BPm (mm-1) 9.86 6 1.32 18.10 6 5.08 0.21 6.70 6 2.78 2.84 6 2.54 0.18 0.052
NOc/BPm (mm-1) 1.03 6 0.14 1.5 6 0.45 0.40 0.71 6 0.14 0.00 6 0.00 0.43 0.096
Tb.Sp. (mm) 431.84 6 42.48 392.56 6 46.68 0.60 441.28 6 126.56 4202 6 989.98 0.03 * 0.001*
Tb.N. (1/mm) 2.29 6 0.2 2.52 6 0.28 0.57 2.68 6 0.57 0.27 6 0.04 0.02 * 0.002*
Histomorphometric parameters were measured in 13 and 78 week old wild type and TTD tibiae (N = 5). T-tests were performed at each time point, p-values are depicted
in the table in the columns ‘‘p-value’’. Interaction between the age and phenotype of the mice was determined by performing 2-way ANOVA’s, p-values are depicted in
the table in the column ‘‘Interaction’’. * = significant difference between wild type and TTD bones, p,0.05.
doi:10.1371/journal.pone.0035246.t001
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unaffected mineralization in TTD mice (data not shown). In
contrast to the number of osteoblast colonies, we did not observe a
significant decrease in adipocyte differentiation potential as
assessed by the number of lipid-vesicle-forming adipocytes in in
vitro cultures (Fig. 6C).
Osteoclastogenesis analyses showed that the total number of
TRAP+ (ACP5+) osteoclasts found in these in vitro cultures was
stable throughout life in wild type mice up to the age of 78 weeks
but significantly decreased in TTD mice (Fig. 6D). When focusing
on multinucleated osteoclasts (.2 nuclei), no significant differences
were observed between wild type and TTD mice although TTD
cultures showed a significant trend towards a decline in
multinucleated osteoclasts with aging (Fig. 6E). Additionally,
osteoclasts were cultured on bone slices to analyze osteoclast
resorption. Only mature osteoclasts are capable of resorbing bone,
so we calculated the average size of a pit formed by a
multinucleated osteoclast (Fig. 6F). For both wild type and TTD
mice we observed a trend towards a decrease in resorption with
aging, both of which did not reach significance (Fig. 6F). No
significant differences were observed between wild type and TTD
mice although at both 26 and 42 weeks, the resorbed area seemed
about twice the size in TTD mice while at 78 weeks it was smaller
(Fig. 6F).
Discussion
The presented data reveal the significance of proper DNA
repair and limiting DNA damage for bone metabolism and
maintaining bone strength with aging. The TTD mice with
impaired DNA repair display loss of bone structure and strength.
Figure 3. Decreased bone strength in TTDmice. Bone strength, mineralization, perimeter, MOI and bone formation rates in long bones of aging
wild type (solid bars or symbols) and TTD males (open bars or symbols). (A) Energy to failure (B) Ultimate load (C) Bone stiffness, (D) bone
mineralization, (C) MOI and (D) perimeter (Pm.). Statistics: a = student t-test; p,0.05 wild type vs. TTD, b2d = 2 way ANOVA; p,0.05. b = significant
difference between wild type and TTD with aging, c = signifcant difference with aging within a genotype, d = a significant interaction between age
and genotype. Error bars represent SEM.
doi:10.1371/journal.pone.0035246.g003
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Mice deficient in DNA repair are partially unprotected against
DNA damage induced by ROS and other types of endogenous
agents as has been shown in previous studies [25] and thereby the
current study supports the concept of DNA damage-induced
skeletal aging [1].
Our findings in aging wild type mice are in line with those
presented in other studies that investigated male mice [4,5]. Age-
related bone loss in humans has been stipulated to be mostly
restricted to cortical bone [6]. We do, however, see a clear
decrease in trabecular bone volume (BV/TV) and trabecular
number along side the decrease in cortical thickness and cortical
volume that was expected. This suggests that not only cortical but
also trabecular bone is subjected to age-related bone loss. These
data correspond with those found in other studies [5]. Analyses of
the 13 weeks old mice demonstrated a temporal difference in
skeletal changes with age between trabecular and cortical bone.
mCT analyses demonstrated already significant differences at
trabecular bone sites between wild type and TTD mice while at
cortical bone sites no differences were found. On basis of the
trabecular data we cannot exclude that in male TTD mice the
observed bone phenotype is partially the result of a developmen-
tal disturbance. Nevertheless, viewing our current histomorpho-
metric analyses and the cortical data of 13 weeks old mice, we
propose that the skeletal phenotype in male TTD mice is
predominantly an age-related phenomenon instead of a devel-
opmental disorder.
We postulate that up to a certain age, somewhere between 13
and 26 weeks, the still functional DNA repair mechanisms in the
TTD mice are able to limit accumulation of DNA damage. This
limits cellular malfunctioning and premature cell death, and
prevents skeletal alterations. However, this fails with progressing
age, leading to premature skeletal aging. In addition, the fact that
clear changes between TTD and wilt type only start to develop
after 26 weeks of age is inherent to the fact that there is an
important temporal component in the process from altered bone
cell function to altered bone turnover and eventual overt skeletal
structural changes.
Figure 4. Periosteal apposition, bone formation and hormone levels. TTD mice lack periosteal apposition at 78 weeks whereas endosteal
apposition is not affected. Calcein labelling at sites of periosteal apposition in 78-week-old (A) wild type and (B) TTD mice. Quantitative analyses of (C)
periosteal and (D) endosteal apposition at 13 and 78 weeks. Serum measurements of bone formation markers and hormones; (E) osteocalcin, (F)
leptin, (G) glucose at 26 and 52 weeks. Statistics: student t-test a = p,0.05 wild type vs. TTD. Error bars represent SEM.
doi:10.1371/journal.pone.0035246.g004
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The large difference in trabecular bone volume and cortical
thickness in 26 weeks old male TTD mice may partially explain
the reduction in bone strength that is already apparent at that age
in TTD mice compared to wild type mice as we do not detect any
significant changes in bone perimeter. In addition, decreased
stiffness has previously been correlated with a loss in ultimate
Figure 5. Regulation of gene expression levels in tibiae. Expression levels measured in RNA extracted from tibiae of 13 and 52 week old wild
type and TTD mice; (A) osteoblast marker genes Bglap and Col1A1. (B) Osteoclast marker genes Acp5 and Ctsk, (C) stress regulated genes Foxo1, Foxo3
and Foxo4, (D) antioxidant enzyme scavengers Sod1, Sod2 and Sod3. Statistics: student t-test a = p,0.05 wild type vs. TTD, b = p,0.05 time point x
vs. time point 13 weeks within one genotype.
doi:10.1371/journal.pone.0035246.g005
Figure 6. Mesenchymal and hematopoietic stem cell differentiation. Mesenchymal and hematopoietic stem cell differentiation in aging wild
type (solid bars) and TTD males (open bars). (A) Average number of ALP+ colonies in ex vivo bone marrow cultures after 14 days of culture. (B)
Average colony size at day 14 of culture. (C) The average number of adipocytes per well. (D) Average number of TRAP+ positive cells per picture. (E)
Average number of mature osteoclasts per picture. (F) Average percentage resorption surface per osteoclast pit per mature osteoclast. Statistics: a =
student t-test; p,0.05 wild type vs. TTD, b2d = 2 way ANOVA; p,0.05. b = significant difference between wild type and TTD with aging, c =
signifcant difference with aging within a genotype, d = a significant interaction between age and genotype. Error bars represent SEM.
doi:10.1371/journal.pone.0035246.g006
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strength and an increased fracture risk [26]. In view of these data,
we would also expect a decrease in MOI in these young mice,
which appears not to be the case in our mCT analysis. However,
MOI in these analyses is only a computational proxy for bone
strength and does not take into account bone composition, making
three point bending tests the more reliable measure. An interesting
observation with respect to maintaining bone strength with aging
is the profound lack of periosteal apposition in TTD mice. Bone is
added to the outside of the cortex in order to compensate loss at
the endocortical side and to maintain bone strength as long as
possible [27,28]. Disturbances in periosteal apposition and lack to
compensate endocortical bone loss will lead to decreased bone
strength and increased fracture risk. Involvement of estradiol, with
opposite roles for estrogen receptors a and ß, testosterone and
mechanical loading in the control of periosteal apposition have
been reported [3]. However, the precise mechanisms underlying
these age-related changes in bone and periosteal apposition are
still poorly understood. Even though the current data do not yet
provide a mechanism behind the lack of periosteal apposition,
TTD mice might prove an excellent model to further unravel this
important skeletal process with aging.
We did not observe an effect on endosteal apposition, whereas
periosteal apposition id severely reduced. This might be explained
by the segmental nature of the TTD phenotype, which has been
previously observed. Where several organs and tissues in TTD
mice are exposed to extremely accelerated aging, others are not
affected at all [21,22,29]. These segmental effects might be due to
differences between cell types, differences in timing and differences
in intracellular metabolic stress levels. In the case of periosteal and
endosteal apposition, timing might be the most important factor.
Endosteal apposition is an important process early on in life, when
redundant DNA repair mechanisms may still be able to limit the
DNA damage. However, with aging periosteal osteoblast activity is
the most important process to compensate for the age-related
increased endosteal bone loss. This allows greater impact of DNA
damage on periosteal than on endosteal apposition with aging.
The observed reduction in bone volume and perimeter
throughout life in wild type and TTD mice will lead to a loss of
bone strength. Up to 78 weeks of age there is a small decrease in
perimeter which is in line with previous reports on cross-sectional
area up to 20 months of age in male wild type mice [4].
Apparently, an increase in perimeter is not important to maintain
bone strength up to this point in life. However, after 78 weeks wild
type mice demonstrate the known age-related increase in
perimeter due to periosteal apposition. Unfortunately, perimeter
data on TTD mice over 78 weeks of age could not be obtained.
Nonetheless, as TTD mice show a strong decrease in periosteal
apposition at 78 weeks, it is unlikely that they would have shown
an increase in perimeter as seen in wild type mice. This implicates
that with progressing age and improper DNA repair a further and
stronger decrease in bone strength will occur. The observed age-
related difference in serum osteocalcin is supportive for a
decreased periosteal bone formation.
Since TTD mice carry a specific defect in TCR combined with
a partial GG-NER deficiency they are predicted to suffer more
from the consequences of cellular DNA damage notably an
increase in senescent or apoptotic cells. Indeed it has previously
been observed that TTD mice even have a decreased spontaneous
tumor formation rate. However, overprotection from cancer likely
caused by enhanced death of cells with DNA damage may at the
same time trigger accelerated aging [15,22,30,31]. In order to get
a first tentative look at how TTD cells might be affected by
accumulating damage, we studied the mRNA expression of a
number of oxidative stress related genes. FOXO proteins play an
important role in the cell’s defense against oxidative stress and
accumulating damage. In addition, FOXO1 can control bone
mass. Osteoblast lineage specific deletion of Foxo1 leads to a
decrease in osteoblast number, bone formation rate and bone
volume [13]. Interestingly we already observed a significant
decrease in Foxo1 expression in 13 weeks old TTD mice. This
indicates that already at this young age, one of the fundamental
mechanisms that protect the cells against stress is decreased and
potentially contributing to decrease in bone structure in TTD
mice. Further support for a role of the FOXO proteins is provided
by the reduced expression of Foxo3 and Foxo4 at 52 weeks in TTD
mice. Our analysis current analyses didn’t reveal a major
difference in the expression of three Sod genes. To address these
antioxidant mechanisms, additional detailed analyses at protein
and functional level are needed but these were beyond the scope of
our current study. The analysis of apoptosis genes in whole tibae
suggest that the skeletal phenotype observed in TTD mice is
independent of apoptosis. Up to 52 weeks no significant differences
between wild type and TTD mice were observed while at 104
weeks pro-apoptotic genes were both down- and up-regulated in
TTD mice. As these analyses are based on expression in whole
tibae differences in apoptotic gene expression in specific subsets of
cells (e.g. osteoblasts, osteoclasts, bone marrow cells including
hematopoietic en mesenchymal stem cells) might have been missed
and will be part of future studies to unravel the role of apoptosis.
An increase in damage and apoptosis can lead to a decrease in
the number of stem and progenitor cells and or change their
differentiation potential. Bone marrow harbors both mesenchymal
and hematopoietic stem cells and their differentiation is tightly
regulated in order to maintain a balance between the number of
osteoblasts and osteoclasts [32,33,34]. Furthermore, the balance
between osteoblast and adipocyte formation within the mesen-
chymal lineage is known to be regulated and can be tipped either
way by disrupting one of the differentiation pathways [35]. The
age-related decrease in wild type osteoblast colony formation
potential we describe is in line with previous data [36].
Our current ex vivo TTD bone marrow cultures, as well as the
histomorphometric data, showed a reduction in the capacity to
form bone nodules and a trend towards reduced osteoclast activity
with age. Taking into account that systemic factors might even
increase the effect of this significant reduction in osteoblasts and
osteoclasts, this could cause a reduction in bone turnover capacity
and thereby a reduced capacity to maintain healthy bone. It is
tempting to conclude that this is part of the mechanism underlying
the observed early onset of skeletal aging and decrease in bone
strength, although the observed effects are too small to be the only
contributing factor. In addition, earlier in life, at 26 and 42 weeks
of age, the number of multinucleated osteoclasts and resorbed area
are higher in TTD mice than in wild type mice, which may also
contribute to the increase in bone loss and increased endocortical
volume earlier in life. This effect on osteoclasts is supported by
preliminary FACS analysis of wild type and TTD bone marrow
(data not shown) showing a shift in HSC differentiation towards
the myeloid lineages in TTD mice.
Overall, these effects on osteogenic and osteoblast precursors
and on osteoclastogenesis in TTD mice may contribute to
accelerated bone aging and loss of bone strength in case of
compromised DNA repair and accumulation of DNA damage.
Although the effects on osteoblast and osteoclast formation are
relatively mild, they are present for a prolonged time, which might
expand and accumulate their final impact on bone formation.
Additionally in vivo systemic processes are most likely involved in
causing the observed changes in bone formation. Hormone levels,
cytokines and growth factors may change with age [37] and
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previous studies on TTD and other DNA repair deficient mice
show that they play an important role in causing the accelerated
aging phenotype observed in these mice. For example the growth
hormone/insulin-like growth factor cascade is impaired in other
murine DNA repair deficient mouse models (Csb/Xpa and Xpf/
Ercc1 mice) and a significant downregulation of the IGF axis was
measured in TTD livers, indicating that this might well be the case
in TTD mice as well [25,38,39]. Downregulation of this axis will
skew the cells towards survival instead of differentiation pathways.
Another study using TTD mice has shown a disturbed PPAR
target gene regulation, which can have wide ranging systemic
effects. This might well explain the discrepancy between the results
from our ex vivo adipocyte cultures and our in vivo observations on
adipocyte tissue formation. PPAR target genes play an important
role in regulating adipocyte differentiation and a disrepancy in
their regulation might very well be the cause of the characteristic
lack of fat deposition in the TTD mice [30].
The lack of adipose tissue in TTD mice disturbs their energy
metabolism and has a profound effect on the leptin levels that are
found in TTD serum. Leptin levels, which regulate appetite and
subsequently food intake, are not significantly different in young
wild type and TTD mice. At 52 weeks however, there is a
profound and significant difference between wild type and TTD
mice. Several studies have shown that leptin directly affects bone
formation, reducing trabecular bone while stimulating cortical
bone formation [40,41]. Logically, a lack in leptin would cause a
loss of cortical bone, which fits our observations and might be one
of the underlying factors for the observed decrease in cortical bone
and loss of periosteal apposition. However, this would not fit our
current observations on trabecular bone implicating that, once
again, additional factors are involved.
In conclusion, accumulation of DNA damage induces skeletal
aging in DNA repair deficient male TTD mice. This effect does
not seem be sex specific. Recent observations in female mice by
our group also show accelerated skeletal aging and loss of bone
strength [42]. Considering the effect of ROS in DNA damage and
aging [1,43,44,45]our study supports the importance of proper
anti-oxidant defence mechanisms and optimal DNA repair for
skeletal maintenance and maintaining bone.
Materials and Methods
Ethics Statement
As required by Dutch law, formal permission to generate and
use genetically modified animals was obtained from the respon-
sible local and national authorities. All animal studies were
approved by the Dutch equivalent of the Institutional Animal Care
and Use Committees, Erasmus MC Dier Ethische Commissie.
Mice and Bones
All mice had a C57BL/6J background and all mice within one
cohort were kept under equal conditions. For micro-computed
tomography (mCT) analysis 8 wild type and TTD mice were
sacrificed at various ages (13–104 weeks). Because of their
reduced lifespan [22] TTD mice within the mCT cohort were not
available for the last time point of wild type mice (104 weeks) and
therefore were only analyzed till 78 weeks. Mice were killed by
cervical dislocation. Femurs and tibiae were isolated and were
either snap frozen in liquid nitrogen and stored at 280uC or
fixed in Burkhardt, which was replaced by 70% ethanol after 3
days. For bone marrow isolation 10 wild type and TTD mice
were sacrificed after which bones were isolated and used for
bone marrow isolation or fixed in 10% formalin for further
testing.
Micro-computed Tomography
Fixed tibiae from wild type and TTD mice (n = 426) were
scanned by mCT from proximal end to mid-diaphysis using the
SkyScan 1072 microtomograph (SkyScan, Antwerp, Belgium) with a
voxel size of 8.82 mm. Bone parameters were quantified using the
following software packages, Nrecon, CT-analyze and Dataviewer
and MatLab (The Mathworks. Natick, MA,USA) (http://www.
skyscan.be/products/downloads.htm). For all mice, a metaphyseal
(100 sections) and a diaphyseal (50 sections) area were selected for
analysis starting respectively 30 or 400 sections below our offset
landmark within the epiphyseal growth plate. We determined the
following parameters; trabecular bone volume fraction (BV/TV),
metaphyseal endocortical volume (metaphyseal Ec.V.), trabecular
number (Tb.N), trabecular thickness (Tb.Th.), cortical thickness
(Ct.Th.), cortical volume, (Ct.V) diaphyseal endocortical volume
(diaphyseal Ec.V)., polar moment of inertia (MOI) and perimeter
(Pm.) [46]. In addition, 3D thickness distribution was determined,
using a larger standardized area located 3.7–6.9 mm from the
proximal end of the bones [47].For additional analysis proximal
tibiae from male wild type and TTD mice at 13 weeks of age were
scanned in the Skyscan 1076 in vivo X-ray microtomograph
(Skyscan, Kontich, Belgium) as previously described [48]. Two
regions were analyzed using the CTAnalyser software package
(Skyscan): cortical thickness (Ct.Th.) and cortical porosity were
determined in 20 cross sections of the mid-diaphysis of the tibia, and
bone volume fraction (BV/TV), trabecular thickness (Tb.Th.) and
cortical thickness (Ct.Th.) were measured in 50 cross sections of the
proximal metaphysis, starting directly underneath the growth plate."
Histomorphometric Analysis
To assess dynamic histomorphometric indices, mice received
intraperitoneal injections with calcein (10 mg/g body weight) 10
and 3 days prior to sacrifice. Tibiae and sections were processed
and stained as described previously [49]. Parameters of static and
dynamic histomorphometry were quantified on not decalcified
proximal tibia sections. For each animal, the bone formation rate
was determined by fluorochrome (calcein) measurements using
two non-consecutive 12mm-sections per animal. Additional
histomorphometric analysis was performed on 13 and 78 week
old wild type and TTD bones as previously described [50].
Mechanical Testing
Defrosted femurs were disposed of residual soft tissue and tested
in a three-point bending assay using a Lloyd LRX mechanical test
frame, constructed with 3 mm hemi-cylindrical supports with a
9 mm total span. The femurs were aligned such that the neutral
axis was parallel to the sagittal plane. The lesser trochanter was
used as a reference point and aligned with one of the two supports.
All samples were preconditioned for 5 cycles to 2 N at a rate of
0.01 mm/s before testing to failure at a rate of 0.02 mm/s. We
measured ultimate load (N), energy (Nmm) and stiffness (N/mm).
Backscatter Scanning Electron Microscopy
Processing and quantitative backscatter scanning electron
microscopic analyses were done as described previously [51].
From each image the histogram of equivalent Z-values was
calculated, its mean value representing the mean mineralization of
the bone tissue [24].
Bone Marrow Isolation, Cell Culture and Cell Culture
Staining
Bone marrow was collected immediately after the bones were
obtained by spinning down the bone marrow into an Eppendorf
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tube at 5000rpm for 2 min. Erythrocytes were lysed using erylysis
buffer (1.55M NH4Cl, 0.1M KHCO3, 1mM EDTA (10x)) and
cells were washed and seeded at 1.000.000 cells/well (12 wells) for
osteoblasts, 100.000 cells/well (96 wells) for osteoclasts and
750.000 cells/well, for adipocytes (24 wells). Osteogenic and
osteoclastogenic cultures were performed as previously described
[52]. Adipocytes were cultured on adipogenic (D-MEM (GIBCO,
Paisley, UK) supplemented with P/S, amphotericin B (250 ng/ml,
Sigma, Zwijndrecht, NL) and 15% heat-inactivated FCS (GIBCO)
medium. Adipogenesis was induced after a 3-week expansion
phase by adding insulin (0.1 mg/ml, Sigma), indomethacin (1 mM,
Sigma) and dexamethasone (1*1027M, Sigma) for two weeks.
Osteoblast colony forming potential and mineralization potential
were determined as previously described after respectively 14 and
21 days of culture [52]. Colonies were counted by eye, next plates
were scanned and colony surface area was determined by
computer analysis (Bioquant software, Nashville, TN, USA).
Alizarin Red staining was extracted and quantified by absorpti-
ometry at 405 nm on a plate reader (Victor2 1420 multilabel
counter, Wallac, Perkin Elmer, Waltham, MA, USA).
Osteoclast number and resorption capacity were determined as
previously described [30] and analyzed using freely available
Image J software (version 1.41;http://rsbweb.nih.gov/ij/). Adipo-
cyte cultures were fixated O/N with 10% formalin, washed with
60% IPOH and stained with Oil-Red O solution (60–40 dilution
of Oil-Red O stock solution (Clin-Tech limited, Guiltford, UK) in
H2O) after which the total amount of adipocytes per well was
determined.
RNA Isolation and qPCR Analysis
After removing tibiae from the mice, we removed the bone
marrow and immediately homogenized the tissue into Trizol using
a Tissuelyser (Qiagen, Venlo, NL). RNA was isolated and purified
using a Qiagen RNeasy kit (Qiagen). Total RNA amount was
determined using a spectrophotometer (ND1000, Nanodrop,
Thermo Scientific, Wilmington, DE, USA). For cDNA synthesis
1 mg of total RNA was reverse transcribed using a cDNA synthesis
kit according to the manufacturer’s protocol (MBI Fermentas,
Thermo Scientific, Wilmington, DE, USA). qPCR analysis was
performed using a ABI 7500 Fats Real-Time PCR detection
system (Applied Biosystems, Carlsbad, CA, USA). Reactions were
performed in 25 ml volumes using a qPCR core kit (for assays
using a probe) or a qPCR kit for SYBR green I (for assays using
SYBR Green) (Eurogentec, Maastricht, NL). Primer and probe
sets were designed using Primer Express software (version 2.0,
Applied Biosystems).
Statistics
We performed 2-way ANOVA statistical analysis on all datasets
to determine any interactions between age and phenotypes, as well
as additional unpaired t-tests with two-tailed P-values to determine
significant difference at each time point (Graph Pad Software, San
Diego, CA, USA, www.graphpad.com).
Supporting Information
Figure S1 Expression of apoptosis related genes in wild
type and TTD tibiae at various ages. Expression levels of
anti- and pro-apoptotic genes were measured in RNA extracted
from tibiae of 13, 52 and 104 week old wild type and TTD mice;
(A-G) pro-apoptotic genes; Cycs, Bax, Casp3, Casp6, Casp7,
Casp9 and Diablo (H-I) Anti-apoptotic genes; Bcl2 and Birc4.
Statistics: student ttest a = p,0.05 wild type vs. TTD.
(TIF)
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